• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: can urine-based metabolomics improve diagnosis of advanced fibrosis in NAFLD?

作者信息

Hagström Hannes

机构信息

Unit of Hepatology, Department of Upper GI, Karolinska University Hospital, Stockholm, Sweden.

Unit of Clinical Epidemiology, Department of Medicine, Karolinska Institutet, Solna, Stockholm, Sweden.

出版信息

Aliment Pharmacol Ther. 2020 Jun;51(11):1204-1205. doi: 10.1111/apt.15744.

DOI:10.1111/apt.15744
PMID:32424917
Abstract
摘要

相似文献

1
Editorial: can urine-based metabolomics improve diagnosis of advanced fibrosis in NAFLD?社论：基于尿液的代谢组学能否改善非酒精性脂肪性肝病中晚期纤维化的诊断？
Aliment Pharmacol Ther. 2020 Jun;51(11):1204-1205. doi: 10.1111/apt.15744.
2
Editorial: can urine-based metabolomics improve diagnosis of advanced fibrosis in NAFLD? Authors' reply.社论：基于尿液的代谢组学能否改善非酒精性脂肪性肝病晚期纤维化的诊断？作者回复。
Aliment Pharmacol Ther. 2020 Jun;51(11):1205-1206. doi: 10.1111/apt.15756.
3
Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study.基于组学和有监督学习的非酒精性脂肪性肝炎和肝纤维化的无创诊断：概念验证研究。
Metabolism. 2019 Dec;101:154005. doi: 10.1016/j.metabol.2019.154005. Epub 2019 Nov 9.
4
[Research advances in diagnosis of non-alcoholic fatty liver disease].非酒精性脂肪性肝病的诊断研究进展
Zhonghua Gan Zang Bing Za Zhi. 2017 Feb 20;25(2):115-118. doi: 10.3760/cma.j.issn.1007-3418.2017.02.007.
5
Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.非酒精性脂肪性肝病中的肝纤维化——具有预后意义的诊断挑战
World J Gastroenterol. 2015 Oct 21;21(39):11077-87. doi: 10.3748/wjg.v21.i39.11077.
6
Editorial: optimising non-invasive screening for advanced liver fibrosis in NAFLD.社论：优化非酒精性脂肪性肝病（NAFLD）中晚期肝纤维化的无创筛查
Aliment Pharmacol Ther. 2017 Nov;46(9):899-900. doi: 10.1111/apt.14267.
7
Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution.非酒精性脂肪性肝病（NAFLD）患者的肝动脉阻力指数（HARI）与非酒精性脂肪性肝病纤维化评分：提示非酒精性脂肪性肝炎（NASH）进展的临界值
J Ultrasound. 2016 Mar 29;19(3):183-9. doi: 10.1007/s40477-016-0203-8. eCollection 2016 Sep.
8
Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations.儿童肥胖和非酒精性脂肪性肝病的尿液代谢组学确定了与饮食习惯和肠-肝轴紊乱相关的代谢途径/代谢物。
Nutrients. 2017 May 11;9(5):485. doi: 10.3390/nu9050485.
9
Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis.伴有肝硬化的非酒精性脂肪性肝病会增加家族性晚期纤维化风险。
J Clin Invest. 2017 Jun 30;127(7):2697-2704. doi: 10.1172/JCI93465. Epub 2017 Jun 19.
10
Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.美国非酒精性脂肪性肝病的患病率以及晚期肝纤维化和死亡的危险因素
PLoS One. 2017 Mar 27;12(3):e0173499. doi: 10.1371/journal.pone.0173499. eCollection 2017.